PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Karolinska Development appoints Viktor Drvota as CIO

Karolinska Development AB has appointed experienced life science investor Viktor Drvota MD PhD as the firm’s new Chief Investment Officer. 

Terje Kalland MD PhD, the Company's Deputy Chief Executive Officer and Chief Scientific Officer, will retire from both positions effective 31 December, 2015.

Dr Drvota joins Karolinska Development from SEB Venture Capital, where he has been Head of Life Science since 2002 and a senior investment manager. Prior to this he was a practising cardiologist at Huddinge University Hospital in Stockholm for 11 years, and since 2002, Associate Professor in Cardiology at Karolinska Institutet, Stockholm.

During his time with SEB Venture Capital, Dr Drvota has established a strong track record in identifying investment opportunities in the life sciences sector (biotech and medtech), building companies and fundraising. Most recently, he led the investor consortium that raised SEK 93 million for Karolinska Development’s medtech portfolio company OssDsign, where he is also a board member. He is also on the board of directors of Nuevolution A/S, which is currently raising SEK 250 million for an IPO on First North Premier in Stockholm, Airsonett AB, SciBase AB (listed), Index Pharmaceuticals AB and Avidicare AB.

Dr Drvota says: ”I am very excited to be joining Karolinska Development and will relish the challenge of creating a leading Nordic Venture Capital company. I believe that my expertise and experience is ideally suited to supporting the development of Karolinska Development’s existing portfolio companies, identifying new opportunities from the exceptional innovation in the region, as well as building relationships with international venture capitalists to create companies with potential to address real unmet medical need and generate significant value for shareholders.”

Chief Executive Officer Jim Van heusden says: ”I am thrilled to have Viktor join the team at this exciting and challenging time. Viktor has an impressive track record and brings with him extensive venture capital experience, which we are confident will help Karolinska Development achieve its goals.”

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured